BRAENDER LORI J (SVP, General Counsel) sold 8.3% of their position (40.10K shares) of AQUESTIVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $167.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2026ACC: 0001214659-26-003145
Officer· SVP, General Counsel
Since Sep 2018
+89.90K
Net shares
Net buyer
$167.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
130K acquired · 40.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+80K
Price / share
—
Trade value
—
% of position
19.9%
3/9/2026
402.98K→482.98K
Common Stock
Direct
Shares
−40.10K
Price / share
$4.17
Trade value
$167.35K
% of position
8.3%
3/10/2026
482.98K→442.88K
Total
Net shares
+39.90K
Net value
-$167.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | A · Award | +80K | — | — | 19.9% | 402.98K | 482.98K |
| Common Stock Direct | 3/10/2026 | S · Sale | −40.10K | $4.17 | $167.35K | 8.3% | 482.98K | 442.88K |
| Total | +39.90K | -$167.35K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
4.29
Held after
50K
Exercisable
—
3/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock50K shares | 3/9/2026 | A · Award | +50K | 4.29 | — | 50K |